Equity

BHSRX

Health Sciences Opportunities Fund

Overview

Loading

Performance

Performance

  • Returns

  1y 3y 5y 10y Incept. Performance data for certain classes of shares of certain funds are based on pre-class inception information dating back to an older class of fund shares. This information may be considered when assessing a fund's performance, but it does not represent actual performance of these classes of shares. The inception date noted under Key Fund Facts is the date the class of shares was incepted. See fund prospectus or fact sheet for details.
7.63 7.83 12.26 15.79 14.44
Benchmark (%) Index: Russell 3000 HealthCare Index.<br /><br /> Index returns are for illustrative purposes only. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results. 5.63 7.93 11.05 15.16 8.25
Morningstar Category Avg. (%) Health 1.39 12.29 9.94 16.24 -
Morningstar Ranking Rankings are based on total return excluding sales charges, independently calculated and not combined to create an overall ranking. 12/137 21/128 14/117 - -
Morningstar Quartile Rankings based on total return excluding sales charges, independently calculated and not combined to create an overall ranking. 1 1 1 2 -
Lipper Category Avg. (%) Health/Biotech Funds -0.84 3.66 9.14 15.46 -
Lipper Ranking Rankings are based on total return excluding sales charges. 12/97 20/87 14/79 - -
Lipper Quartile Rankings are based on total return excluding sales charges. 1 1 1 - -
  YTD 1m 3m 1y 3y 5y 10y Incept. Performance data for certain classes of shares of certain funds are based on pre-class inception information dating back to an older class of fund shares. This information may be considered when assessing a fund's performance, but it does not represent actual performance of these classes of shares. The inception date noted under Key Fund Facts is the date the class of shares was incepted. See fund prospectus or fact sheet for details.
7.63 -8.23 -10.29 7.63 25.36 78.28 333.20 1,202.05
Benchmark (%) Index: Russell 3000 HealthCare Index.<br /><br /> Index returns are for illustrative purposes only. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results. 5.63 -9.03 -10.73 5.63 25.73 68.88 310.36 351.77
Morningstar Category Avg. (%) Health 9.30 9.30 1.86 1.39 41.60 60.63 350.33 -
Lipper Category Avg. (%) Health/Biotech Funds -0.84 -10.34 -16.55 -0.84 12.45 56.17 326.88 -
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted. The performance information for periods prior to the inception date of the share class are based on the Fund’s Investor A Shares, adjusted to reflect the fees and expenses applicable to such share class. See the fund prospectus for more details.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart

Key Facts

Key Facts

Size of Class (Millions) as of Feb 19, 2019 $235.4 M
Size of Fund (Millions) as of Feb 19, 2019 $7,087.5 M
Share Class launch date Sep 12, 2011
Asset Class Equity
Morningstar Category Health
Lipper Classification Health/Biotech Funds
Benchmark Index Russell 3000 HealthCare Index
CUSIP 091936815
Number of Holdings as of Jan 31, 2019 116
Max Offer Price as of Feb 19, 2019 $56.90
Open to New Investors Yes
Turnover Percent as of Jan 31, 2019 39%

Portfolio Characteristics

Portfolio Characteristics

Average Market Cap (Millions) The average size of the securities the fund invests in. as of Jan 31, 2019 $ 90,722.7 M
Best 3-Month Return Over the Last 3 Years 3 months ending Sep 30, 2018 12.82%
Worst 3-Month Return Over the Last 3 Years 3 months ending Dec 31, 2018 -10.29%
Fund Standard Deviation (3y) as of Jan 31, 2019 13.19

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Ratings

Ratings

Morningstar Rating

Overall Morningstar Rating for Health Sciences Opportunities Fund, Class R, as of Jan 31, 2019 rated against 132 Health Funds.

Lipper Leader

 
Overall Lipper Leaders ratings based on an equal-weighted average of percentile ranks for each measure over 3-, 5-, and 10-year periods (if applicable) and do not take into account the effects of sales charges for these categories (Consistent Return, Preservation, Total Return, Expense, and Tax Efficiency) as of Jan 31, 2019 out of 88, 12,205, 88, 44 and 88 Funds, respectively in Lipper's Health/Biotech Funds classification.

Holdings

Holdings

as of Dec 31, 2018
Name Weight (%)
UNITEDHEALTH GROUP INC 7.98
PFIZER INC 6.25
ABBOTT LABORATORIES 5.47
BOSTON SCIENTIFIC CORPORATION 4.26
MERCK & CO INC 3.74
Name Weight (%)
MEDTRONIC PLC 3.63
STRYKER CORPORATION 2.74
ANTHEM INC 2.65
CIGNA HOLDING CO 2.49
BRISTOL-MYERS SQUIBB CO 2.33

Exposure Breakdowns

Exposure Breakdowns

as of Dec 31, 2018

% of Market Value

Type Fund Benchmark Net
as of Dec 31, 2018

% of Market Value

Type Fund Benchmark Net
as of Dec 31, 2018

% of Market Value

Type Fund Benchmark Net
as of Dec 31, 2018

% of Market Value

Type Fund Benchmark Net
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team

  

Portfolio Manager

Literature

Literature

Loading fund documents...
No documents found
Checkout {{ translations['submit'][selectedAction] }} {{ responseMessage }} {{ warningMessage }} You have previously requested to be opted out of all BlackRock Literature Services emails. To subscribe, you must opt back in.